← All trials
NCT02099175
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2013
- Primary completion
- Jan 1, 2020
- Completion date
- Jan 1, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of MilanLead sponsor
- Presidio Ospedaliero Spedali Civili di BresciaOverall official - principal investigator
- A.O. Ospedale di Circolo e Fondazione MacchiOverall official - principal investigator
- Regione LombardiaCollaborator
- University of PaviaOverall official - principal investigator
- University of MilanStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.